Omsk Region secures month-long supply of kidney disease medications

Omsk Region secures month-long supply of kidney disease medications

Robert Howard
Robert Howard
1 Min.
A pharmacy shelf filled with various types of medicines, including boxes, arranged neatly on the racks.

Omsk Region secures month-long supply of kidney disease medications

The Omsk Region has secured at least a one-month supply of essential medications for patients with chronic kidney diseases. Local health officials confirm that the most widely used treatments, including epoetin alfa, remain available in sufficient quantities for the time being.

Earlier shortages of epoetin alfa 2,000 IU, reported in October, are set to ease. Authorities have announced that fresh stock will reach pharmacies by November 7. This follows concerns over limited access to the medication in previous weeks.

Patients in Omsk currently receive their treatments intravenously at dialysis centres. No reports of shortages have come from those undergoing care at these facilities. The region's supply chain appears stable for now.

Without access to real-time data from Izvestia or official health sources, the broader medication situation across other Russian regions remains unverified. Current information applies only to Omsk's confirmed stockpiles.

The Omsk Region's kidney disease patients have a guaranteed supply of critical drugs for at least the next month. Epoetin alfa, previously in short supply, will soon return to pharmacies. Dialysis centres continue to operate without disruption, ensuring ongoing treatment for those in need.

Neueste Nachrichten